Synova's Fem-V soon available in Duane Reade Pharmacies
Synova Healthcare says it has increased the distribution of Fem-V, its at-home kit for the diagnosis of vaginal infections, through a deal with Duane Reade, the largest pharmacy chain in the New York metropolitan area. The agreement will see the product reach the shelves of the drug store, which has some 250 branches in the region, in late September.
Stephen King, chairman of of the Synova Healthcare group, said that the distribution agreement constituted a significant achievement for the company, and builds on similar deals with Rite Aid, Happy Harry's stores, as well as Kinney Drug, Lewis Drug and Kerr Drug.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze